Get started
Cel-Sci CorporationCel-Sci CorporationCel-Sci Corporation

Cel-Sci Corporation

No trades
See on Supercharts
OverviewFinancialsNewsIdeasDiscussionsForecastSeasonals

CVM chart


Full chart

CVM upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪83.69 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−9.82 USD
Net income (FY)
‪−26.92 M‬ USD
Revenue (FY)
0.00 USD
Shares float
‪7.34 M‬
Beta (1Y)
1.72

About Cel-Sci Corporation


Sector
Health Technology
Industry
Biotechnology
CEO
Geert R. Kersten
Website
cel-sci.com
Headquarters
Vienna
Founded
1983
ISIN
US1508377066
FIGI
BBG000H5G6L5
CEL-SCI Corp. is a clinical-stage biotechnology company, which engages in the research, development, and manufacture of investigational immunotherapy products for the treatment of cancer and infectious diseases. Its product pipeline includes Multikine and Ligand Epitope Presentation System (LEAPS). Multikine is an investigational immunotherapy for the potential treatment of head and neck cancers. LEAPS is categorized into LEAPS-H1N1-DC, a product candidate for the treatment of pandemic influenza for hospitalized patients and CEL-2000 and CEL-4000, which are vaccine candidates for the treatment of rheumatoid arthritis. The company was founded by Maximilian de Clara on March 22, 1983 and is headquartered in Vienna, VA.

Check out other big names from the same industry as CVM.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

CVM news



Ideas



See all ideas 

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


Depending on the exchange, the stock ticker may vary. For instance, on BOATS exchange Cel-Sci Corporation stocks are traded under the ticker CVM.
We've gathered analysts' opinions on Cel-Sci Corporation future price: according to them, CVM price has a max estimate of 60.00 USD and a min estimate of 60.00 USD. Watch CVM chart and read a more detailed Cel-Sci Corporation stock forecast: see what analysts think of Cel-Sci Corporation and suggest that you do with its stocks.
CVM reached its all-time high on Dec 27, 2023 with the price of 95.10 USD, and its all-time low was 2.52 USD and was reached on Jun 30, 2025. View more price dynamics on CVM chart.
See other stocks reaching their highest and lowest prices.
Yes, you can track Cel-Sci Corporation financials in yearly and quarterly reports right on TradingView.
Cel-Sci Corporation is going to release the next earnings report on Dec 19, 2025. Keep track of upcoming events with our Earnings Calendar.
CVM net income for the last quarter is ‪−5.66 M‬ USD, while the quarter before that showed ‪−6.57 M‬ USD of net income which accounts for 13.81% change. Track more Cel-Sci Corporation financial stats to get the full picture.
No, CVM doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, CVM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Cel-Sci Corporation stock right from TradingView charts — choose your broker and connect to your account.